HeXun Competitors

Stocks . Taiwan . 
Stock . HeXun Biosciences Co
6986 Stock   60.40  0.60  1.00%   
HeXun Biosciences competes with Brillian Network, STL Technology, Kung Long, Dah San, and I Sheng; as well as few others. Analyzing HeXun Biosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of HeXun Biosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

HeXun Biosciences vs P Duke Correlation

Good diversification

The correlation between HeXun Biosciences Co and 8109 is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HeXun Biosciences Co and 8109 in the same portfolio, assuming nothing else is changed.

HeXun Biosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between HeXun Biosciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of HeXun and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of HeXun Biosciences does not affect the price movement of the other competitor.

High positive correlations

6115
+ 0.8
4931
8109
+ 0.8
2489
6940
+ 0.72
6895
6115
+ 0.72
1537
6115
+ 0.69
1615
3015
+ 0.68
6895
  

High negative correlations

1615
- 0.77
6895
6788
- 0.76
6895
6940
- 0.73
6788
6115
- 0.71
6895
8109
- 0.65
6940
4931
- 0.61
6895

Risk-Adjusted Indicators

There is a big difference between HeXun Stock performing well and HeXun Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HeXun Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
6895  2.40 (0.31) 0.00 (0.91) 0.00 
 0.00 
 4.29 
(6.39)
 16.72 
6788  2.35  0.54  0.14 (1.03) 2.76 
(2.79)
 4.62 
(4.24)
 17.07 
6940  1.62 (0.20) 0.00  0.34  0.00 
 0.00 
 3.94 
(3.37)
 14.94 
4931  2.83  0.22  0.05  0.43  3.48 
(3.02)
 6.45 
(5.78)
 17.89 
1537  0.53 (0.02)(0.09)(0.05) 0.61 
(0.79)
 1.22 
(1.20)
 4.02 
1615  0.75  0.12  0.08  1.06  0.56 
(0.99)
 1.98 
(1.21)
 5.15 
6115  0.27  0.02 (0.14) 6.70  0.26 
(0.35)
 0.74 
(0.63)
 1.91 
3015  1.68 (0.06) 0.00 (0.07) 0.00 
 0.00 
 3.91 
(3.42)
 10.63 
2489  2.31  0.71  0.34  0.83  1.53 
(3.19)
 9.84 
(2.96)
 15.51 
8109  1.08  0.18  0.10  1.97  0.95 
(1.43)
 2.82 
(1.94)
 6.26 

HeXun Biosciences Competitive Analysis

The better you understand HeXun Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, HeXun Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across HeXun Biosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6986 6895 6788 6940 4931 1537 1615 6115 3015 2489
 1.00 
 60.40 
HeXun
 1.97 
 199.00 
Wave
 0.78 
 316.00 
Brillian
 1.08 
 27.50 
Gus
 2.78 
 157.50 
STL
 0.40 
 124.50 
Kung
 0.50 
 49.85 
Dah
 0.32 
 47.40 
6115
 1.08 
 55.00 
FSP
 10.00 
 24.20 
Amtran
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Not too volatile
Market Performance
(90 Days Performance)
Fair
Weakest
Good
Weakest
Mild
Weak
Good
Fair
Weakest
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
Unknown
Low
Unknown
Small
Low
Low
Low
Low
Small
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Hold
Strong Buy
Cautious Hold
Strong Buy
Current Ratio
N/A
N/A
3.35
N/A
N/A
4.41
1.74
2.11
1.77
2.42
Net Asset
N/A
N/A
N/A
N/A
1.38 B
5.25 B
3.55 B
8.74 B
21.18 B
26.74 B
Profit Margin
N/A
N/A
21.7
N/A
0.059
0.13
0.0946
0.11
0.0509
-0.15
EBITDA
N/A
N/A
243.94 M
N/A
(6.48 M)
968.11 M
567.44 M
823.05 M
1.32 B
6.82 B
Operating Margin
N/A
N/A
27.8
N/A
0.0365
0.13
0.0954
0.085
0.0318
0.0027
Current Valuation
N/A
N/A
7.17 B
N/A
2.98 B
9.72 B
4.54 B
6.56 B
4.42 B
(1.88 B)
Price To Book
N/A
N/A
8.92
N/A
3.0
2.61
1.8
1.58
0.57
0.56
Retained Earnings
N/A
N/A
N/A
N/A
N/A
1.76 B
334 M
2.13 B
2.23 B
3.51 B
Current Asset
N/A
N/A
N/A
N/A
N/A
3.74 B
978 M
6.82 B
9.94 B
19.98 B
Five Year Return
N/A
N/A
N/A
N/A
N/A
5.39
3.86
7.03
4.92
N/A
Beta
N/A
N/A
N/A
N/A
0.27
0.26
0.5
0.22
0.81
1.0
Number Of Employees
N/A
N/A
N/A
N/A
2
16
11
14
20
3.51 K
Shares Outstanding
N/A
N/A
30.25 M
N/A
63.97 M
82.07 M
148.84 M
187.66 M
187.26 M
798 M
Cash Flow From Operations
N/A
N/A
174.23 M
N/A
(418.94 M)
590 M
828.17 M
29.25 M
31.32 M
886.33 M
Annual Yield
N/A
N/A
N/A
N/A
0.0229
0.05
0.0597
0.0651
0.0826
0.0732
Total Debt
N/A
N/A
70.48 M
N/A
N/A
137.67 M
186.84 M
1.86 B
199.33 M
5.9 M
Return On Equity
N/A
N/A
23.25
N/A
0.16
0.23
0.17
0.17
0.0645
-0.18
Z Score
N/A
N/A
58.2
N/A
1.0
51.4
15.4
2.4
22.2
N/A
Return On Asset
N/A
N/A
13.44
N/A
0.0361
0.11
0.0711
0.0478
0.015
0.0013
Book Value Per Share
N/A
N/A
25.5
N/A
16.89
52.56
15.87
26.8
67.69
17.47
Current Liabilities
N/A
N/A
N/A
N/A
N/A
1.35 B
707 M
2.97 B
5.89 B
9.85 B
Total Asset
N/A
N/A
N/A
N/A
1.38 B
5.25 B
3.55 B
8.74 B
21.18 B
26.74 B
Debt To Equity
N/A
N/A
0.082
N/A
N/A
3.2
34.5
39.3
11.0
0.067
Last Dividend Paid
N/A
N/A
4.0
N/A
N/A
7.0
1.85
2.8
3.3
0.71
Target Price
N/A
N/A
N/A
N/A
N/A
180.0
N/A
41.75
39.9
22.96
Shares Owned By Institutions
N/A
N/A
N/A
N/A
6.24
18.8
N/A
0.82
4.36
7.2
Market Capitalization
N/A
N/A
6.88 B
N/A
3.21 B
11.57 B
4.59 B
8.08 B
7.48 B
8.02 B
Price To Earning
N/A
N/A
45.9
N/A
N/A
13.18
9.38
13.8
94.02
63.82
Price To Sales
N/A
N/A
8.37
N/A
1.28
1.58
1.0
1.04
0.46
0.41
Net Income
N/A
N/A
178.46 M
N/A
(39.67 M)
620.04 M
451.3 M
507.48 M
754.08 M
5.02 B
Earnings Per Share
N/A
N/A
4.96
N/A
2.55
11.1
2.69
4.28
4.2
-3.78
Shares Owned By Insiders
N/A
N/A
35.2
N/A
37.39
28.08
66.33
46.74
38.94
14.05
Revenue
N/A
N/A
822.43 M
N/A
1.49 B
5.8 B
4.52 B
7.73 B
16.65 B
22.23 B
Working Capital
N/A
N/A
N/A
N/A
N/A
2.39 B
271 M
3.85 B
4.05 B
10.13 B
Cash And Equivalents
N/A
N/A
528.82 M
N/A
N/A
1.38 B
185.33 M
4.17 B
2.86 B
8.41 B
Cash Per Share
N/A
N/A
16.74
N/A
N/A
16.9
1.66
22.2
14.87
10.55
Gross Profit
N/A
N/A
376.19 M
N/A
154.1 M
1.22 B
657.26 M
1.19 B
2.43 B
1.82 B
Day Typical Price
60.47
202.0
316.83
27.6
159.0
124.5
50.02
47.4
55.5
23.53
Accumulation Distribution
4326.34
15113.29
41803.96
12724.4
192583.0
0.008
1741.77
0.0084
15358.57
2.4 M
Market Facilitation Index
0.0
0.0
0.0
0.0
0.0
1.0
0.0
0.4
0.0
N/A
Daily Balance Of Power
0.2
(0.40)
(0.19)
(0.50)
(0.69)
0.5
(0.31)
0.375
(0.32)
1.1
Period Momentum Indicator
0.6
(4.00)
(2.50)
(0.30)
(4.50)
0.5
(0.25)
0.15
(0.60)
2.2
Rate Of Daily Change
1.01
0.98
0.99
0.99
0.97
1.0
1.0
1.0
0.99
1.1
Day Median Price
60.5
203.5
317.25
27.65
159.75
124.5
50.1
47.4
55.75
23.2
Price Action Indicator
0.2
(6.50)
(2.50)
(0.30)
(4.50)
0.25
(0.37)
0.075
(1.05)
2.1
Relative Strength Index
N/A
46.44
51.95
44.9
48.83
51.88
59.3
56.01
48.85
77.75
Coefficient Of Variation
874.64
(1,186)
611.38
(1,036)
1364.65
27817.1
720.39
1311.24
(11,991)
426.83
Mean Deviation
1.49
2.4
2.35
1.62
2.83
0.5279
0.7452
0.2708
1.68
2.31
Jensen Alpha
0.2093
(0.31)
0.5436
(0.20)
0.2213
(0.02)
0.1213
0.0179
(0.06)
0.7054
Total Risk Alpha
0.0268
(0.60)
0.2021
(0.49)
(0.1)
(0.08)
0.0325
(0.02)
(0.25)
0.4488
Sortino Ratio
0.0732
N/A
0.1381
N/A
0.0513
(0.09)
0.0812
(0.14)
N/A
0.3402
Downside Variance
4.62
N/A
10.06
N/A
14.26
0.7097
0.5299
0.1397
N/A
4.24
Standard Deviation
2.08
3.25
3.17
2.5
3.75
0.7306
1.01
0.3683
2.24
3.33
Kurtosis
1.01
1.01
1.42
7.37
0.7129
0.6294
1.77
0.8654
0.3948
2.33
Potential Upside
4.75
4.29
4.62
3.94
6.45
1.22
1.98
0.7431
3.91
9.84
Treynor Ratio
0.8579
(0.91)
(1.03)
0.3397
0.4318
(0.05)
1.06
6.7
(0.07)
0.8311
Maximum Drawdown
9.75
16.72
17.07
14.94
17.89
4.02
5.15
1.91
10.63
15.51
Variance
4.34
10.59
10.06
6.25
14.07
0.5338
1.02
0.1356
5.02
11.12
Market Risk Adjusted Performance
0.8679
(0.90)
(1.02)
0.3497
0.4418
(0.04)
1.07
6.71
(0.06)
0.8411
Risk Adjusted Performance
0.0904
(0.05)
0.1277
(0.06)
0.0618
0.0026
0.1046
0.046
6.0E-4
0.1797
Skewness
0.3218
(0.09)
(0.08)
1.99
0.2164
0.1702
1.07
0.3153
(0.03)
1.38
Semi Deviation
1.78
N/A
2.76
N/A
3.48
0.6139
0.563
0.256
N/A
1.53
Information Ratio
0.0755
(0.11)
0.138
(0.13)
0.0517
(0.11)
0.0586
(0.14)
(0.04)
0.21
Value At Risk
(3.81)
(6.39)
(4.24)
(3.37)
(5.78)
(1.20)
(1.21)
(0.63)
(3.42)
(2.96)
Expected Short fall
(1.61)
N/A
(2.79)
N/A
(3.02)
(0.79)
(0.99)
(0.35)
N/A
(3.19)
Downside Deviation
2.15
N/A
3.17
N/A
3.78
0.8424
0.7279
0.3737
N/A
2.06
Semi Variance
3.15
N/A
7.64
N/A
12.14
0.3769
0.3169
0.0655
N/A
2.35

HeXun Biosciences Competition Performance Charts

Five steps to successful analysis of HeXun Biosciences Competition

HeXun Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by HeXun Biosciences in relation to its competition. HeXun Biosciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of HeXun Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact HeXun Biosciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to HeXun Biosciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your HeXun Biosciences position

In addition to having HeXun Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel
Apparel Theme
Companies manufacturing textile accessories and apparel products. The Apparel theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for HeXun Stock Analysis

When running HeXun Biosciences' price analysis, check to measure HeXun Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HeXun Biosciences is operating at the current time. Most of HeXun Biosciences' value examination focuses on studying past and present price action to predict the probability of HeXun Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HeXun Biosciences' price. Additionally, you may evaluate how the addition of HeXun Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY